专利摘要:
Novel peptide derivatives which are acyl derivatives of luminol (5-amino-2,3-dihydro-1,4-phthalazinedione) or isoluminol (6-amino-2,3-dihydro-1,4-phthalazinedione) where the acyl residue is an amino acid or amino acid sequence with 2 to 4 amino acid residues, coupled with an amide bond, and where the alpha -amino group is either free or acylated, methods for their preparation and a method for laboratory diagnostics of proteases using the peptide derivatives. The derivatives are intended for quantitative determination of proteases or proteas-activity by release of luminol or isoluminol which in their free state can be brought to luminate intensely, but lose considerably in luminiscence when they are amide-bound to a peptide sequence.
公开号:SU1233806A3
申请号:SU823496751
申请日:1982-09-23
公开日:1986-05-23
发明作者:Роджер Зимонссон Лайф;Ари Элли Зало;Эрик Аурелл Лайф;Геран Клэсон Карл
申请人:Кабивитрум Аб (Фирма);
IPC主号:
专利说明:

This invention relates to biochemistry, in particular, to a method for determining the activity of a serine protease. .
The aim of the invention is: increasing the sensitivity of the method.
The method is carried out as follows.
A substrate is added to the enzyme containing material — a labeled substance containing amimic acid derivatives of the general formula
R, (Aj), - (.- R, where R is hydrogen, aqdl;
And - valine, isoleucine, alanine,
glycine;
A - proline, phenylalanine, glycez valine, pipeccoline derivative of glutamic acid pyroglutamic acid., Leucine S alanine, glutamine ™, va acid; Glutamic acid methyl ester, arginine, isoleucine. tyrosine;
A - phenylalanine, proline, leucii series, glycine, valine. alanine;
And, - arginine, lysine; RJ - luminol, isolumicol; n - O or.
The reaction of the protease and the substrate is carried out under conditions that ensure the optimal reaction for the given; 1 winter. Depending on the degree of protease activity and substrate concentration, the reaction is carried out for 055-5 minutes
: they discontinue before the next: - by using an acid or a hen of 5 pr -1 baud 1 rt to change the pH with: c 5 to ensure the cessation of the e;
Then, the amount of the released: char1: eper is LYuM 1Nola or isoluminol, 11Pr: is divided by adding- and oxidizing agent: I-J measuring the amount of light emitted at the same time using a subcode or device. At the same time, the amount of free g arker is linearly proportional to the amount of significant, therefore the amount of light pre c. Is a measure for protease activity.
P p and; ep I, To a solution containing 100 microns, urokinase and 200 microliters of 10 And pG7u-Gily Arg-Ts2 / -HCt-, 800 microliters of gCis buffer with a pH of 9.0 was added with an ionic strength of 0.05. The mixture is incubated at 3 for 5 min. Substrate hydrolysis is stopped by addition of 20% -; acetic acid; 50 media are selected, in which the spectrofluorogactically determine the amount of released marker (isolumine), which corresponds to 0.01 gdc of urokin ase,
Example 2 To the solution according to npi jwepy, containing thrombin as the ph & rnc j, the substance with the structure is added as a substrate, n: pIEe; den. In table. I. The amount of enzyme (MKZ), which can be detected with the help of used substrates, is determined.
The results are summarized in table. one.
T,;, b l and n and I
Note: Boe - tertiary butyloxycarbonyl,
Cho - carbobenzoxy, Bz - benzoi.n, pGGi - pyroglutamic acid.
ts
PRI me R 3. Repeated with the use of serine enzymes, the method according to example 1, the substrates, according to the table. 2
Table 2
UrokinazpGhu-Ghy-Arg-IsI
- -pGhu-Ghy-Arg-pNa
Thrombin Tos-Phe-Pro-Arg-IsI
- -H-D-Phe-pip-Arg-pNa
PlasminBoc-Val-Leu-Lys-IsI
- -H-D-Val-Leu-Lys-pNa
The data presented shows that the use of the invention (examples, 3, and 5) makes it possible to increase the sensitivity of the method for determining the activity of serine proteases in comparison with the known method (examples 2, 4 and 6).
Example 4: The procedure of the method according to Example 1 is repeated. 5.0 10 M trypsin is used as an enzyme, and the following are used as substrates:
VNIIPI Order 2789/60 Circulation 490
Subscription
Random polygons pr-tie, Uzhgorod, st. Project, 4
Continued tabl,)
0.01 units 0.5 units
0.01 10 units
3.5 10 units
0.02-10 units of casein
1 1 About unit of casein
H-D-VaT-Len-Arg-IsI-2HCr; Cbo-GIy-Pro-Arg-IsI-HCI;
Boc-IIe-GIuCNCjH,) -Cly-Arg-IsI HCl;
H-Phe-Pro-Arg-IsI;
Bz-Arg-Lum-HCJ;
Bz-Arg-IsI HCI; H-D-Leu-Ser-Arg-IsI-2HC;
Cbo-Cly-Gly-Arg-Lum-AcOH;
Ac-Ala-Pro-Arg-IsI;
Suc-aja-pro-lys-isst;
H-0-Arg-VaI-Tyr-IsI-2HCl. The amount of released marker corresponds to that used in
enzyme concentration experience.
Subscription
权利要求:
Claims (1)
[1]
METHOD FOR DETERMINING SERIN PROTEASE ACTIVITY by reacting an enzyme-containing material with a labeled substance containing amino acid derivatives, characterized in that a labeled substance is of the general formula ^ - (AD - (AD - (AD-A, -R ,.
where R is hydrogen, acyl;
A q - valine, isoleucine, alanine, glycine;
A - proline, phenylalanine, glycine, valine, the pipecoline derivative of glutamic acid, pyroglutamic acid, leucine, alanine, glutamic acid, glutamic acid methyl ester, arginine, isoleucine, tyrosine;
A - phenylalanine, proline, leucine, <© serine, glycine, valine, alanine;
A. - arginine, Lysine;
F g - luminol, isoluminol;
η ’- 0 or 1.
>
SM i 23 3806
类似技术:
公开号 | 公开日 | 专利标题
SU1233806A3|1986-05-23|Method of estimating activity of serine protease
US4457866A|1984-07-03|Chromogenic compounds and their use as enzyme substrates
Auld et al.1970|Kinetics of carboxypeptidase A. II. Inhibitors of the hydrolysis of oligopeptides
McRae et al.1981|Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates
US4188264A|1980-02-12|Process for determining bacterial endotoxin and reagents used therefor
CA1258221A|1989-08-08|Reagent for the determination of the prothrombin time
US5035999A|1991-07-30|Aminoluciferin derivatives, processes for the production thereof and their application in the determination of enzyme activities
US4508644A|1985-04-02|Chromogenic compounds, a process for their preparation and their use
US5591591A|1997-01-07|Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
Hemker2012|Handbook of synthetic substrates
Lockridge1982|Substance P hydrolysis by human serum cholinesterase
CA2363827A1|2000-08-31|Oligopeptide derivatives for the electrochemical measurement of protease activity
Mattler et al.1977|Serine protease specificity for peptide chromogenic substrates
US20130344520A1|2013-12-26|Thrombin Substrate and Assay for Determining the Level of Bioactive Thrombin in a Sample
EP0802986B1|2001-09-19|Methods of determining endogenous thrombin potential | and thrombin substrates for use in said methods
US4563305A|1986-01-07|Radiolabelled substrates for assaying mammalian enzymes
Vencill et al.1985|Clostridium histolyticum collagenase: development of new thio ester, fluorogenic, and depsipeptide substrates and new inhibitors
Hojima et al.1980|Enzymatic properties of human Hageman factor fragment with plasma prekallikrein and synthetic substrates
AU622895B2|1992-04-30|A method and a kit containing means for the kinetic determination of factor xiii
Swanson et al.1981|Lens exopeptidases
NZ207626A|1987-05-29|Photometric determination of activated partial thromboplastin and reagent therefor
Machuga et al.1984|Isolation and characterization of an aminopeptidase from Lactobacillus acidophilus R-26
JP2006201176A|2006-08-03|Stable chromogenic test reagent and use in coagulation-diagnostic tests therefor
Louis et al.1998|Specificity of Pseudomonas aeruginosa serralysin revisited, using biologically active peptides as substrates
HU0302136A2|2003-09-29|Gallic acid derivatives and use for exploring endogenetic coagulation
同族专利:
公开号 | 公开日
DE3164437D1|1984-08-02|
JPS57501234A|1982-07-15|
AT8130T|1984-07-15|
EP0046742B1|1984-06-27|
US4748116A|1988-05-31|
EP0046742A1|1982-03-03|
WO1982000641A1|1982-03-04|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题

IL42124A|1972-05-02|1977-02-28|Kabi Ab|Substrate for the determination of proteolytic enzymes|
SE380257B|1972-05-02|1975-11-03|Bofors Ab|NEW DIAGNOSTIC OPERATING SUBSTRATES WITH HIGH SPECIFICITY FOR THROMBIN AND OTHER PROTEOLYTIC ENZYMES OF THE PEPTIDYL-PEPTIDE HYDROLASES|
US4018884A|1975-06-26|1977-04-19|Hoffmann-La Roche Inc.|Fluorogenic materials and labeling techniques|
DE2527932C2|1974-07-02|1983-04-21|Pentapharm AG, 4052 Basel|Acid addition salts of tripeptide derivatives and their use as substrates for the determination of plasma kallikrein|
US4162941A|1974-12-05|1979-07-31|Ab Kabi|Method for determining a proteolytic enzyme|
SE407058B|1974-12-05|1979-03-12|Kabi Ab|NEW CHROMOGENA ENZYME SUBSTRATE FOR SERINE PROTEASES|
US4011219A|1975-03-28|1977-03-08|Chugai Seiyaku Kabushiki Kaisha|Phthalazine derivatives and salts thereof|
US4261893A|1975-04-28|1981-04-14|Miles Laboratories, Inc.|Bis-phthalimide intermediates|
CH622286A5|1975-06-23|1981-03-31|Pentapharm Ag|
US4137225A|1975-07-11|1979-01-30|Ab Kabi|Novel chromogenic enzyme substrates|
US4247454A|1975-07-11|1981-01-27|Ab Kabi|Novel chromogenic thrombin substrates|
US4061625A|1975-07-11|1977-12-06|Ab Kabi|Novel chromogenic thrombin substrates|
US4181650A|1975-08-25|1980-01-01|Maier Charles L Jr|Procedure for the assay of pharmacologically immunologically and biochemically active compounds in biological fluids|
US4056519A|1976-05-10|1977-11-01|Eli Lilly And Company|Substrate for assay of plasmin|
SE437153B|1976-12-01|1985-02-11|Kabi Ab|SPECIFIC CHROMOGENA ENZYM SUBSTATE FOR SERINE PROTEASES|
US4147692A|1977-02-26|1979-04-03|Ajinomoto Co., Inc.|Novel dipeptide derivatives, and method of measuring enzymatic activity|
DE2824917A1|1977-07-13|1979-02-01|Corning Glass Works|BIOLOGICALLY ACTIVE CONJUGATES|
SE7811630L|1977-11-17|1979-05-18|Welsh Nat School Med|METHOD OF DETECTION OR QUANTITATION OF SUBSTANCES USING LABELING TECHNIQUES|
US4335041A|1977-11-25|1982-06-15|Ventrex Laboratories, Inc.|High sensitivity assays for angiotensin converting enzyme|
US4276378A|1977-11-25|1981-06-30|Ryan James W|High sensitivity assays for angiotensin converting enzyme|
SE7801373L|1978-02-07|1979-08-08|Kabi Ab|EASY SPLABLE SUBSTRATE FOR QUANTIFIATION OF PROTEASES|
IL60888A|1978-06-16|1984-07-31|Yeda Res & Dev|Substrates and process for the quantitative assay of enzymes|
AT387393B|1978-07-18|1989-01-10|Kabi Ab|METHOD FOR PRODUCING NEW TRIPEPTIDE DERIVATIVES|
US4334069A|1978-07-24|1982-06-08|Miles Laboratories, Inc.|Chemiluminescent phthalhydrazide-labeled hapten conjugates|
US4225485A|1978-07-24|1980-09-30|Miles Laboratories, Inc.|Chemiluminescent naphthalene-1,2-dicarboxylic acid hydrazide-labeled polypeptides and proteins|
US4275153A|1978-08-03|1981-06-23|American Hospital Supply Corporation|Analytical fluorogenic substrates for proteolytic enzymes|
US4336186A|1978-08-03|1982-06-22|Gargiulo Robert J|Analytical fluorogenic substrates for proteolytic enzymes|
JPS6134440B2|1978-08-10|1986-08-07|Ajinomoto Kk|
JPS6126917B2|1978-10-30|1986-06-23|Torii Yakuhin Kk|
JPS6126918B2|1978-10-30|1986-06-23|Torii Yakuhin Kk|
JPS59499B2|1978-11-02|1984-01-07|Ajinomoto Kk|
US4216142A|1978-12-18|1980-08-05|Abbott Laboratories|Chromogenic substrates for the proteolytic enzymes|
DE2854987A1|1978-12-20|1980-06-26|Boehringer Mannheim Gmbh|DIAGNOSTIC AGENTS FOR DETECTING PROTEOLYTIC ENZYMS AND CHROMOGENS SUITABLE FOR THIS|
US4217269A|1979-03-23|1980-08-12|Abbott Laboratories|Dipeptide chromogenic substrates|
US4260682A|1979-04-04|1981-04-07|Ryan James W|High sensitivity assays for angiotensin converting enzyme|
US4327178A|1979-05-01|1982-04-27|University Of Miami|Urinary kallikrein assay: specific substrates and assay method|
US4221706A|1979-06-14|1980-09-09|Abbott Laboratories|Chromogenic substrates|
US4351760A|1979-09-07|1982-09-28|Syva Company|Novel alkyl substituted fluorescent compounds and polyamino acid conjugates|
US4318846A|1979-09-07|1982-03-09|Syva Company|Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers|
US4259233A|1979-10-23|1981-03-31|Miles Laboratories, Inc.|β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates|
US4308202A|1979-10-25|1981-12-29|Torii & Co., Ltd.|Prolylphenylalanylarginine derivatives, process for producing same and method for measuring activity of enzymes using same|
US4244865A|1979-12-03|1981-01-13|Abbott Laboratories|α hydroxy tripeptide substrates|ZA832844B|1982-05-18|1984-03-28|Smithkline Beckman Corp|Oligopeptide prodrugs|
GB2124233B|1982-07-19|1985-09-18|Nat Res Dev|Synthetic peptides and their preparation|
DK201084A|1983-04-28|1984-10-29|Kimberly Clark Co|PROCEDURE FOR DETERMINING CATHEPSIN B IN THE PRESENCE OF OTHER PROTEOLYTIC ENZYMES AND RELATIONSHIPS FOR USING THE PROCEDURE|
GB8312339D0|1983-05-05|1983-06-08|Austen B M|Peptides|
CA1293591C|1985-01-11|1991-12-24|Charles A. Kettner|Peptide substrates for detecting virus-specified protease activity|
EP0255341B1|1986-07-29|1993-02-03|Sunstar Kabushiki Kaisha|Reagent for testing periodontal diseases|
DE3629175A1|1986-08-28|1988-03-17|Behringwerke Ag|CHROMOGENIC COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE|
FR2622581B1|1987-11-03|1990-02-16|Inorgan Sa Rech Develop Pharm|NOVEL L-PROLINE DERIVATIVES, THEIR PREPARATION AND THEIR BIOLOGICAL APPLICATIONS|
US5320945A|1989-07-14|1994-06-14|Boehringer Mannheim Gmbh|Method and reagent for the determination of antithrombin III|
EP0428000A1|1989-11-03|1991-05-22|Abbott Laboratories|Fluorogenic substrates for the detection of proteolytic enzyme activity|
SE8904188D0|1989-12-12|1989-12-12|Kabivitrum Ab|CHROMOGENIC SUBSTRATE|
US5003050A|1990-03-07|1991-03-26|The United States Of America As Represented By The Secretary Of The Air Force|Diazoluminomelanin and a method for preparing same|
CH683966A5|1993-02-19|1994-06-30|Limad Marketing Exp & Imp|Compounds of the ftalidrazidici class as active substances in anti-hypoxic agents and defense.|
CH683965A5|1993-02-19|1994-06-30|Limad Marketing Exp & Imp|Ftalidrazidici compounds of the class as an active substance in anti-inflammatory agents and anti-toxic.|
US20030114410A1|2000-08-08|2003-06-19|Technion Research And Development Foundation Ltd.|Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis|
WO2004106541A1|2003-05-30|2004-12-09|Kyushu Tlo Company, Limited|Periodontal disease marker|
US7863042B2|2003-06-18|2011-01-04|Chugai Seiyaku Kabushiki Kaisha|Fucose transporter|
CN100549183C|2003-06-23|2009-10-14|Nlc药品公司|The enzymatic diagnostic test of SARS and other virus disease|
US20050191704A1|2004-03-01|2005-09-01|Kimberly-Clark Worldwide, Inc.|Assay devices utilizing chemichromic dyes|
US7906276B2|2004-06-30|2011-03-15|Kimberly-Clark Worldwide, Inc.|Enzymatic detection techniques|
US7521226B2|2004-06-30|2009-04-21|Kimberly-Clark Worldwide, Inc.|One-step enzymatic and amine detection technique|
US7094528B2|2004-06-30|2006-08-22|Kimberly-Clark Worldwide, Inc.|Magnetic enzyme detection techniques|
WO2006067847A1|2004-12-22|2006-06-29|Chugai Seiyaku Kabushiki Kaisha|Method of preparing antibody by use of cell having its fucose transporter function inhibited|
US7504235B2|2005-08-31|2009-03-17|Kimberly-Clark Worldwide, Inc.|Enzyme detection technique|
US8003399B2|2005-08-31|2011-08-23|Kimberly-Clark Worldwide, Inc.|Nitrite detection technique|
US8758989B2|2006-04-06|2014-06-24|Kimberly-Clark Worldwide, Inc.|Enzymatic detection techniques|
CN100464189C|2006-04-21|2009-02-25|深圳市新产业生物医学工程有限公司|Magnetic separating direct chemical illuminating reagent and testing method using the same reagent|
US7897360B2|2006-12-15|2011-03-01|Kimberly-Clark Worldwide, Inc.|Enzyme detection techniques|
US7935538B2|2006-12-15|2011-05-03|Kimberly-Clark Worldwide, Inc.|Indicator immobilization on assay devices|
AU2008282739B2|2007-08-02|2013-12-19|Gilead Biologics, Inc.|Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis|
US8180421B2|2007-12-12|2012-05-15|Kimberly-Clark Worldwide, Inc.|Resonance energy transfer based detection of nosocomial infection|
WO2010080769A2|2009-01-06|2010-07-15|Arresto Biosciences, Inc.|Chemotherapeutic methods and compositions|
US20100290948A1|2009-05-15|2010-11-18|Xuedong Song|Absorbent articles capable of indicating the presence of urinary tract infections|
US20110044907A1|2009-08-21|2011-02-24|Derek Marshall|In vivo screening assays|
SG178845A1|2009-08-21|2012-04-27|Gilead Biologics Inc|Catalytic domains from lysyl oxidase and loxl2|
BR112012008080A2|2009-08-21|2017-07-04|Gilead Biologics Inc|in vivo screening assays.|
US20110207144A1|2009-08-21|2011-08-25|Derek Marshall|In vitro screening assays|
EP2467162A4|2009-08-21|2013-10-02|Gilead Biologics Inc|Therapeutic methods and compositions|
RU2549684C2|2010-02-04|2015-04-27|Джилид Байолоджикс, Инк.|Antibodies binding to lysyl oxidase-like enzyme-2 , and method for preparing them|
WO2017061288A1|2015-10-06|2017-04-13|国立大学法人東京工業大学|Method for measuring tyrosine phosphatase and tyrosine kinase activity|
法律状态:
优先权:
申请号 | 申请日 | 专利标题
SE8005940|1980-08-25|
[返回顶部]